You are here

Article metrics

Article menu
Oncolytic and local immunotherapy
Original research
Phase I/II study of PexaVec in combination with immune checkpoint inhibition in refractory metastatic colorectal cancer

 

Online download statistics by month:

Online download statistics by month: February 2023 to January 2026

AbstractFullPdf
Feb 2023733743269
Mar 2023727730173
Apr 202325425579
May 202316316570
Jun 202313613743
Jul 202312012061
Aug 202317517868
Sep 202314714876
Oct 202310710737
Nov 202311611637
Dec 2023989957
Jan 202411411494
Feb 202415515752
Mar 2024979872
Apr 202411812395
May 2024878859
Jun 2024889156
Jul 202410811063
Aug 2024757452
Sep 2024868632
Oct 2024939367
Nov 202413013250
Dec 202417517780
Jan 202512312390
Feb 202516917157
Mar 202510610668
Apr 202511211271
May 202510610962
Jun 2025676735
Jul 2025110
Jan 2026001
Total478648302126